Evaluation of a Diabetes Treatment and Education Program for Insulin Pump Therapy (INPUT) (INPUT)
Evaluation of a Newly Developed Treatment and Education Program (INPUT) for Diabetic Patients Performing an Insulin Pump Therapy
Studieöversikt
Detaljerad beskrivning
INPUT is a self-management-based treatment and education program for diabetic patients with an insulin pump (CSII). It is designed to empower patients to adequately perform their therapy in daily life and to integrate their diabetes and their insulin pump into their lifes in order to enhance quality of life.
INPUT ist tested in an randomized controlled trial (RCT) with a waiting-list control group since no certified and effective treatment and education program for CSII exists.
This study is a multi-center study. Study centers are specialized diabetes practices throughout Germany. Patients will be approached by their respective practice and informed about the study. Study measurements as well as the conduct of INPUT will take place at the respective practice.
Baseline measurement will take place 2 weeks prior to the beginning of INPUT. After completion of baseline measurement, all patients from one study center will be randomized centrally by the Research Institute of the Diabetes Academy Mergentheim (FIDAM). 2 weeks and 6 months after the completion of INPUT, follow-up measurements will be conducted at the respective study center.
HbA1c as a marker of glycemic control will be analyzed in a central laboratory. Secondary outcome measures will be assessed via psychometrically tested questionnaires, Case Reports Forms, or patient files.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Neuss, Tyskland, 41462
- Diabetologische Schwerpunktpraxis Neuss
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Existing insulin pump therapy
- Prior participation in a structured diabetes education program
- HbA1c ≥ 7,5% but ≤ 13%
- Ability to understand, speak and write German language
- informed consent (if necessary, informed consent of the parents)
Exclusion Criteria:
- Diabetes duration < 1 year
- severe organic disease preventing a regular participation in the training course
- pregnancy
- severe cognitive impairment
- current treatment of psychiatric disorder
- renal disease requiring dialysis
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: INPUT
INPUT consists of 12 lessons comprising all relevant information in order to treat diabetes with an insulin pump.
Patients learn to effectively use the different features of their pump in order to improve not only glycemic control but also to improve the implementation of pump therapy in daily life.
Psychological and motivational aspects of living with diabetes and living with an insulin pump are addressed as well.
|
Treatment and education program based on the self-management theory of behavioral medicine. The program is delivered by certified and specially trained diabetes educators.
Andra namn:
|
|
Inget ingripande: Waiting list
Patients are randomly assigned to the waiting list.
After completion of the 6-month follow-up, these patients will also receive training with INPUT.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Changes in Glycemic Control Measured by A1c
Tidsram: 6 months
|
Difference between baseline A1c and A1c at the 6-month follow-up
|
6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Hypoglycaemia Awareness
Tidsram: 6 months
|
The hypoglycemia awareness questionnaire provides a score indicating the severity of hypoglycaemia unawareness.
This scale ranges from 0 (maximum hypoglycaemia awareness) to 7 (minimum hypoglycaemia awareness), where a score of 4 suggests reduced hypoglycaemia awareness.
|
6 months
|
|
Diabetes Empowerment
Tidsram: 6 months
|
Empowerment is measured by a German version of the Diabetes Empowerment Scale, a measure of diabetes-related psychosocial self-efficacy.
|
6 months
|
|
Problem Areas in Diabetes
Tidsram: 6 months
|
The Problem Areas in Diabetes Scale (PAID) assesses the psychosocial adaptation to the burden of living with and treating diabetes.
|
6 months
|
|
Satisfaction with current treatment
Tidsram: 6 months
|
Satisfaction with current treatment is assessed via a 10-item scale.
The total score ranges from 10 to 60 with lower scores indicating higher satisfaction.
|
6 months
|
|
Diabetes Self-Management
Tidsram: 6 months
|
The Diabetes Self-Management Questionnaire is a self-report measure of patients' self-care.
The level of self-care is assessed via Likert scales.
|
6 months
|
|
Diabetes Distress
Tidsram: 6 months
|
The Diabetes Distress Scale (DDS) assesses diabetes-related stressors due to living and treating diabetes.
Different aspects of distress are covered: emotional burden, physician-related, regimen-related, diabetes-related interpersonal
|
6 months
|
|
Health-related Quality of Life
Tidsram: 6 months
|
Health-related quality of life focuses on the health-specific aspects of quality of life and dealing with a chronic condition such as diabetes
|
6 months
|
|
Depressive symptoms
Tidsram: 6 months
|
The presence and extent of typical depressive symptoms are assessed via self-report
|
6 months
|
|
Attitudes towards insulin pump therapy
Tidsram: 6 months
|
Specific attitudes towards different aspects of insulin pump therapy are assessed via Likert scales.
The questionnaire consists of 6 subscales that can be placed within 4 dimensions: (I) Expectations on insulin pump therapy (subscale: achieving better glycaemic control) (II) Perceived advantages of an insulin pump (subscale: gaining more flexibility) (III) Ease of use (subscales: design + functionality) (IV) Psychosocial effects and barriers (subscales: technological dependence + impaired body image)
|
6 months
|
|
Severe hypoglycaemia
Tidsram: 6 months
|
The incidence of severe hypoglycaemia in the past six months is assessed via Case Report Forms.
Severe hypoglycaemia is defined as requiring third party assistance or medical intervention for treating hypoglycaemia.
|
6 months
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Norbert Hermanns, PhD, Forschungsinstitut der Diabetes Akademie Mergentheim (FIDAM GmbH)
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- NH012016
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .